Ken Griffin Staar Surgical CO Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Staar Surgical CO stock. As of the latest transaction made, Citadel Advisors LLC holds 555,116 shares of STAA stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

555,116

Previous 102,100 443.7%

Holding current value

$15.2 Million

Previous $1.8 Million 417.44%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$15.09 - $20.27 $4.64 Million - $6.24 Million	307,625 Added 124.3%	555,116 $9.31 Million
Q1 2025 May 15, 2025	SELL	$15.35 - $24.99 $1.14 Million - $1.85 Million	-74,033 Reduced 23.03%	247,491 $4.36 Million
Q4 2024 Feb 14, 2025	SELL	$23.93 - $35.89 $14.7 Million - $22 Million	-612,804 Reduced 65.59%	321,524 $7.81 Million
Q3 2024 Nov 14, 2024	BUY	$29.97 - $47.42 $23.6 Million - $37.4 Million	787,895 Added 538.06%	934,328 $34.7 Million
Q2 2024 Aug 14, 2024	SELL	$38.07 - $52.25 $2.18 Million - $3 Million	-57,385 Reduced 28.16%	146,433 $6.97 Million
Q1 2024 May 15, 2024	SELL	$27.67 - $39.61 $5.67 Million - $8.12 Million	-204,999 Reduced 50.14%	203,818 $7.8 Million
Q4 2023 Feb 14, 2024	SELL	$30.6 - $43.78 $16.4 Million - $23.5 Million	-536,756 Reduced 56.77%	408,817 $12.8 Million
Q3 2023 Nov 14, 2023	BUY	$39.39 - $58.12 $24.9 Million - $36.7 Million	631,948 Added 201.5%	945,573 $38 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $72.82 $15.7 Million - $22.6 Million	310,990 Added 11802.28%	313,625 $16.5 Million
Q1 2023 May 15, 2023	SELL	$51.25 - $79.34 $3.37 Million - $5.22 Million	-65,795 Reduced 96.15%	2,635 $168,000
Q4 2022 Feb 14, 2023	BUY	$46.82 - $76.2 $1.04 Million - $1.68 Million	22,110 Added 47.73%	68,430 $3.32 Million
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $2.53 Million - $4 Million	35,888 Added 344.02%	46,320 $3.27 Million
Q2 2022 Aug 15, 2022	SELL	$50.24 - $80.48 $4.43 Million - $7.1 Million	-88,196 Reduced 89.42%	10,432 $740,000
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $491,090 - $791,945	-8,470 Reduced 7.91%	98,628 $7.88 Million
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $1.43 Million - $2.07 Million	16,226 Added 17.86%	107,098 $9.78 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $8.03 Million - $10.6 Million	-65,445 Reduced 41.87%	90,872 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$105.76 - $154.96 $1.49 Million - $2.19 Million	14,108 Added 9.92%	156,317 $23.8 Million
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $8.12 Million - $13.1 Million	103,496 Added 267.34%	142,209 $15 Million
Q4 2020 Feb 16, 2021	BUY	$55.93 - $82.78 $1.18 Million - $1.75 Million	21,172 Added 120.7%	38,713 $3.07 Million
Q2 2020 Aug 14, 2020	SELL	$29.15 - $61.54 $1.3 Million - $2.74 Million	-44,602 Reduced 71.77%	17,541 $1.08 Million
Q1 2020 May 15, 2020	BUY	$25.01 - $42.4 $492,797 - $835,449	19,704 Added 46.43%	62,143 $2.01 Million
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $485,378 - $753,868	19,771 Added 87.22%	42,439 $1.49 Million
Q3 2019 Nov 14, 2019	SELL	$25.78 - $34.8 $551,949 - $745,067	-21,410 Reduced 48.57%	22,668 $584,000
Q2 2019 Aug 14, 2019	SELL	$23.08 - $37.01 $2.08 Million - $3.33 Million	-89,932 Reduced 67.11%	44,078 $1.3 Million
Q1 2019 May 15, 2019	SELL	$27.81 - $40.78 $1.8 Million - $2.64 Million	-64,638 Reduced 32.54%	134,010 $0
Q4 2018 Feb 14, 2019	BUY	$28.91 - $50.0 $2.95 Million - $5.11 Million	102,155 Added 105.87%	198,648 $6.34 Million
Q3 2018 Nov 13, 2018	BUY	$30.85 - $50.65 $2.98 Million - $4.89 Million	96,493 New	96,493 $0
Q4 2017 Feb 09, 2018	SELL	$12.45 - $17.4 $172,258 - $240,746	-13,836 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$10.25 - $12.8 $141,819 - $177,100	13,836	13,836 $172,000

Others Institutions Holding STAA

# of Institutions

195

Shares Held

53.1M

Call Options Held

178K

Put Options Held

114K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.32B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account